Wayfinder Biosciences is a biotechnology company developing orally-available small molecule drugs that modulate the function of the RNAs encoding key disease targets.
The company’s proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting small molecules. Wayfinder’s programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease.
Wayfinder was founded by RNA scientists from the University of Washington and is based in Seattle.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 4000 Mason Rd, Seattle,washington 98195,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://wayfinderbio.com
- HQ
- Seattle, Washington
Wayfinder Biosciences Questions
Wayfinder Biosciences's website is https://wayfinderbio.com
Wayfinder Biosciences's LinkedIn profile is https://www.linkedin.com/company/wayfinder-biosciences
Wayfinder Biosciences has
15 employees.
View email and phone details for 15
employees at Wayfinder Biosciences.
Wayfinder Biosciences's industry is
Biotechnology Research
Wayfinder Biosciences's top competitors are
Monod Bio,
Adyn,
Umoja Biopharma,
Daiichi Sankyo Us,
Sonoma Biotherapeutics, Inc.,
Talus Bio,
Parse Biosciences,
Outpace Bio,
Cajal Therapeutics,
Shape Therapeutics Inc..
Wayfinder Biosciences's categories are Biotechnology Research
Wayfinder Biosciences's founding year is 2021
